Bacteria in recalled eye drops linked to cases of vision loss, surgical removal of eyeballs

Recalled eye drops have caused dozens of infections and cases of vision loss, surgical removal of eyeballs, and one death, according to the US Centers for Disease Control and Prevention. The Artificial Tears Lubricant Eye Drops, distributed by EzriCare and Delsam Pharma, were recalled in early February, and 68 patients in 16 states have now been identified with infections of a rare strain of drug-resistant Pseudomonas aeruginosa that had never before been reported in the US. Although patients reported using different brands, EzriCare Artificial Tears was the brand most commonly reported. The recalled products contained undeclared water, which could compromise sterility. The recall is not linked to adverse events so far. The US Food and Drug Administration and CDC have urged consumers to stop using the recalled products. Global Pharma has not responded to requests for comment.

Further recalls of eye drops have been announced but are not connected to adverse events: Pharmedica USA is recalling anti-inflammatory Purely Soothing 15% MSM Drops because of “non-sterility”, while Apotex is recalling Brimonidine Tartrate Ophthalmic Solution 0.15% over concerns that cracks in some of the bottle tops may affect sterility and lead to adverse events.

Eye drops are generally safe when manufactured and used correctly, according to Dr. Thomas Steinemann, clinical spokesperson for the American Academy of Ophthalmology. However, he said the recalls highlighted the importance of safe use, particularly with preservative-free eye drops such as EzriCare Artificial Tears, where contamination could lead to serious infection. He also recommended washing hands before touching the bottle or the eye, avoiding touching the top of the bottle to eyelashes and skin, and not using expired products.



Source link